Guangzhou ophthalmic surgical robot developer Weimou Medical completes nearly RMB 100 million Series A financing

▤ Summary

Weimou Medical, a Guangzhou-based developer of ophthalmic surgical robots, closed a nearly RMB 100 million Series A round. The company focuses on intelligent microsurgery robotics for eye procedures and aims to build a high-precision, automated assistant for complex retinal surgery. It also completed China’s first multicenter randomized controlled registration clinical trial for an ophthalmic surgical robot. The new capital will support product registration, commercialization, core technology iteration, and ecosystem development.

$ Funding

▦ Linked Companies